(Q34666435)

3 August 2017

1 reference

title

Psychiatric symptoms in Parkinson's disease (English)

1 reference

3 August 2017

Karen E Anderson

1

1 reference

3 August 2017

William J Weiner

series ordinal

2

1 reference

3 August 2017

publication date

1 July 2002

1 reference

Current Neurology and Neuroscience Reports

3 August 2017

published in

1 reference

3 August 2017

volume

2

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

303-309

1 reference

Altered serotonin metabolism in depressed patients with parkinson's disease

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0005-6

Classification of fluctuations in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0005-6

Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0005-6

Depression and Parkinson's disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0005-6

Treatment of depression in Parkinson's disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0005-6

Effectiveness of ECT in patients with parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0005-6

Bupropion in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0005-6

Evidence for atypical depression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0005-6

Visual hallucinations associated with Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0005-6

Early dopaminergic drug-induced hallucinations in parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0005-6

Levodopa-induced psychosis: a kindling phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0005-6

Quetiapine (Seroquel) in the treatment of psychosis in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0005-6

Anxiety and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0005-6

Psychotic complications of long-term levodopa treatment of Parkinson's disease

21 January 2018

1 reference

12 December 2020

Obsessive-compulsive disorder: evidence for basal ganglia dysfunction

1 reference

12 December 2020

Depression in Parkinson's disease

1 reference

12 December 2020

Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease.

1 reference

12 December 2020

Parkinson's disease and anxiety: comorbidity with depression

1 reference

12 December 2020

SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study.

1 reference

12 December 2020

A Golgi study of human locus coeruleus in normal brains and in Parkinson's disease.

1 reference

12 December 2020

Theoretical implications of the use of L-dopa in parkinsonism. A review

1 reference

12 December 2020

"Panic attacks" in Parkinson's disease. A long-term complication of levodopa therapy

1 reference

12 December 2020

Anxiety disorders in patients with Parkinson's disease

1 reference

12 December 2020

What contributes to depression in Parkinson's disease?

1 reference

12 December 2020

Depression in Parkinson's disease: a psychosocial viewpoint

1 reference

12 December 2020

Anxiety disorders in familial parkinsonism.

1 reference

12 December 2020

Clozapine and risperidone treatment of psychosis in Parkinson's disease

1 reference

12 December 2020

A survey of antidepressant drug use in Parkinson's disease. Parkinson Study Group

1 reference

12 December 2020

Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia

1 reference

12 December 2020

Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study

1 reference

12 December 2020

Risperidone for hallucinations in levodopa-treated Parkinson's disease patients

1 reference

12 December 2020

Autonomic failure, depression and anxiety in Parkinson's disease.

1 reference

12 December 2020

Non-recognition of depression and other non-motor symptoms in Parkinson's disease

1 reference

12 December 2020

Range of neuropsychiatric disturbances in patients with Parkinson's disease

1 reference

12 December 2020

Quetiapine-Induced extrapyramidal side effects in patients with Parkinson's disease: case report

1 reference

12 December 2020

Preliminary examination of the comorbidity of anxiety and depression in Parkinson's disease

1 reference

12 December 2020

Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease

1 reference

12 December 2020

The relationship of serotonin to depression in Parkinson's disease

1 reference

12 December 2020

Depression in Parkinson's disease

1 reference

12 December 2020

Parkinson's disease: drug-induced psychiatric states.

1 reference

12 December 2020

Depression in Parkinson's disease: biogenic amines in CSF of "de novo" patients

1 reference

12 December 2020

Gender differences in Parkinson's disease symptom profile

1 reference

12 December 2020

Depression in classic versus akinetic-rigid Parkinson's disease

1 reference

12 December 2020

Managing the neuropsychiatric symptoms of Parkinson's disease

1 reference

12 December 2020

1 reference

12 December 2020

Biochemistry of Parkinson's disease 28 years later: a critical review

1 reference

12 December 2020

Neuropsychological profile linked to low dopamine: in Alzheimer's disease, major depression, and Parkinson's disease.

1 reference

12 December 2020

Affective symptoms in multiple system atrophy and Parkinson's disease: response to levodopa therapy

1 reference

12 December 2020

Prospective study of hallucinations and delusions in Parkinson's disease

1 reference

12 December 2020

1 reference

12 December 2020

Risperidone in Parkinson's disease

1 reference

12 December 2020

Efficacy of quetiapine in Parkinson's patients with psychosis

1 reference

12 December 2020

Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease.

1 reference

12 December 2020

Obsessive-compulsive symptoms in Parkinson's disease

1 reference

12 December 2020

Depressive symptoms in Parkinson's disease: a comparison with disabled control subjects

1 reference

12 December 2020

Parkinson's disease: a preliminary study of yohimbine challenge in patients with anxiety

1 reference

12 December 2020

10.1007/S11910-002-0005-6

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1027090731

0 references

1 reference